Source: The Business Journals: Raleigh/Durham

Cambridge Biomedical: Behind the deal: Why a Triangle company is buying its competitor in Cambridge

A Triangle company says buying a Massachusetts competitor will enhance its line of business and provide a desirable client base in a booming life science region.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Barbara Osband's photo - Chairman & CEO of Cambridge Biomedical, Inc.

Chairman & CEO

Barbara Osband

CEO Approval Rating

81/100

Read more